When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Phase 3 cancer immunotherapy company, CEL-SCI ( NYSE: CVM ) prices an underwritten confidentially marketed public offering of 794,117 shares at an offering price of $1.70 per share.
The closing of the offering is expected to take place on or about May 2, 2023.
Underwriters' have a 30-day option to purchase up to an additional 15% of the shares.
Gross proceeds are expected to be ~$1.35M.
The stock price was down 6.1% during pre-market hours.